TABLE 4.
Univariable and Multivariable Fine and Gray Competing Risks Regression Regarding Mortality Within 14 Days From Waitlist Registration
Univariable Model SHR (95% CI) |
Multivariable Model 1 SHR (95% CI) |
Multivariable Model 2* SHR (95% CI) |
Multivariable Model 3† SHR (95% CI) |
|
---|---|---|---|---|
Status 1a | Reference | Reference | Reference | Reference |
ACLF-3 | 1.67 (1.53–1.83) | 1.45 (1.31–1.61) | 1.43 (1.29–1.59) | |
MELD-Na score <36 | Reference | Reference | 1.30 (1.16–1.47)* | |
MELD-Na score 36–40 | 1.06 (0.96–1.17) | 1.16 (1.04–1.29) | 1.38 (1.22–1.56)* | |
MELD-Na score >40 | 1.49 (1.36–1.64) | 1.51 (1.37–1.67) | 1.77 (1.59–1.97)* | |
MELD-Na score | 1.03 (1.02–1.03) | 1.03† (1.02–1.03) | ||
Age | 1.01 (1.01–1.02) | 1.01 (1.01–1.01) | 1.01 (1.01–1.02) | |
Male | 0.90 (0.83–0.98) | 0.91 (0.83–0.98) | 0.90 (0.83–0.98) | |
Albumin | 1.00 (0.95–1.06) | 1.04 (0.98–1.08) | 1.01 (0.96–1.07) | |
HCV | 0.93 (0.84–1.03) | 0.94 (0.86–1.03) | 0.93 (0.84–1.03) | |
ALD | 0.83 (0.75–0.94) | 0.85 (0.76–0.95) | 0.84 (0.75–0.94) | |
Listed, years 2009–2014 | 0.89 (0.82–0.97) | 0.87 (0.81–0.95) | 0.89 (0.82–0.97) |
Interaction between ACLF-3 and MELD-Na category.
MELD-Na analyzed as continuous variable.